Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05370560Completed

Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation

Role: lead

NCT05267457Completed

Associations of Plasma Vanadium Concentrations With Gestational Diabetes Mellitus

Role: lead

NCT05146401Completed

Associations of Plasma Fatty Acid Patterns With Gestational Diabetes Mellitus

Role: lead

NCT05035966Completed

Association of β-amyloid 40 and 42 With Prediabetes

Role: lead

NCT03130894Completed

Association Between TMAO and Diabetes

Role: lead

All 5 trials loaded